Physician
Nahid Rashid, MD
According to 2025 Medicare claims, Nahid Rashid, MD (NPI: 1306366448) practices hematopoietic cell transplantation and cellular therapy in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is SOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP (NPI: 1134151657; TIN: 951750445) and primary practice location at 90027-5822.
Rashid's data goes back to 2015 and runs through 2024. Part D data shows 713 prescription claims across 106 beneficiaries totaling $621,321 in drug costs, led by Jakafi (Ruxolitinib Phosphate). Open Payments data shows 1 records totaling $21. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,473 to $621,321. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.